ÇмúÇà»ç
Korean Society of Gastrointestinal Cancer Research
Korean Society of Gastrointestinal Cancer Research
¼¼Á¾´ëÇб³ ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 2023-04-01
08:30-09:00 | µî·Ï | |
09:00-09:10 | Àλ縻 | |
Session I | Mini-review of ASCO/ESMO GI Cancer Symposium (What¡¯s new in 2023) | ÁÂÀå: ·ùÁö°ï (¼¿ïÀÇ´ë), ÀÓÀ±Á¤(µ¿±¹ÀÇ´ë) |
09:10-09:35 | Esophageal/stomach cancer | °¼±Çü (Ãæ³²ÀÇ´ë) |
09:35-10:00 | Colorectal cancer | ¿Àµ¿ÁØ (µ¿±¹ÀÇ´ë) |
10:00-10:25 | Pancreatobiliary cancer | ½Åµ¿¿ì (ÇѸ²ÀÇ´ë) |
10:25-10:45 | Coffee break | |
Session II | IASGO Joint Session : Debate or Controversial Issues of GI Cancer (English) | ÁÂÀå: ¼Û½Ã¿µ(¿¬¼¼ÀÇ´ë), Kyoichi Takaori(Kyoto Univ., Japan) |
10:45-11:10 | Meaning of circulating tumor DNA in the colorectal cancer (KSGC) | ±Ýº¸¶ó (°í·ÁÀÇ´ë) |
11:10-11:35 | Perioperative circulating tumor DNA as markers of colorectal cancer (IASGO) | Scott Kopetz (The University of Texas, MD Anderson Cancer Center, USA) |
11:35-12:00 | Updates in perihilar cholangiocarcinoma - preoperative evaluation, drainage, and treatment - Gastroenterologist¡¯s viewpoint (KSGC) | °ÈÆò (°¡ÃµÀÇ´ë) |
12:00-12:25 | Updates in perihilar cholangiocarcinoma - preoperative evaluation, drainage, and treatment - Surgeon¡¯s viewpoint (IASGO) | Etsuro Hatano (Kyoto Univ., Japan) |
Luncheon Symposium | ±è¼º¼ö (°¡Å縯ÀÇ´ë) | |
12:25-12:50 | Riding the new waves of success: the role of immune-oncology in Advanced BTC | ¹æ½Â¹Î (¿¬¼¼ÀÇ´ë) |
12:50-13:20 | ´ëÇѼÒȱâ¾Ï¿¬±¸ÇÐȸ Á¤±âÃÑȸ | |
Session III | Updates On the Treatment of Unresectable Pancreatic Cancer | ÁÂÀå: ¹Ú½Â¿ì (¿¬¼¼ÀÇ´ë), ȲÁøÇõ (¼¿ïÀÇ´ë) |
13:20-13:45 | Real-world outcomes of palliative chemotherapy for pancreatic cancer | Á¶ÁßÇö (¿¬¼¼ÀÇ´ë) |
13:45-14:10 | Opportunities and benefits beyond second line chemotherapy | ÀüÁß¿ø (±¹¸³¾Ï¼¾ÅÍ) |
14:10-14:35 | Emerging role of local ablation treatment | ±è¸¸µæ (¿¬¼¼ÀÇ´ë ¿µ»óÀÇÇаú) |
14:35-15:00 | New treatment targets and therapeutic application | ¹ÚÁÖ°æ (¼º±Õ°üÀÇ´ë) |
15:00-15:20 | Coffee break | |
Session IV | À±¸®À§¿øȸ ¼¼¼Ç (Çʼö¼¼¼Ç) | ÁÂÀå: ¹Úº´±Ô(±¹¹Î°Ç°º¸ÇèÀϻ꺴¿ø), ±è¼ºÈÆ (ÀüºÏÀÇ´ë) |
15:20-15:50 | Ç×¾ÏÄ¡·á¿¡¼ÀÇ ÀÇ·áÀ±¸®ÀÇ ¿ªÇÒ | Á¶¹éÇö (±Â¸ð´×º´¿ø) |
15:50-16:20 | ¿¬¸íÀÇ·á °áÁ¤ Á¦µµ¿¡ ´ëÇÑ À±¸®Àû °íÂû | ÇÑÁ¤È£ (ÃæºÏÀÇ´ë) |
16:20-16:50 | ºòµ¥ÀÌÅÍ¿Í ÀÇ·áÁ¤º¸ È°¿ëÀÇ À±¸®Àû ÀïÁ¡ | ±Çº¹±Ô (ÀÌÈÀÇ´ë ÀÇÇб³À°Çаú) |
16:50-17:00 | Best Presentation Award | |
17:00 ~ | Adjourn |
Session I | Gastrointestinal Cancer: Laboratory Bench to Clinic | ÁÂÀå: ÀüÈÆÀç (°í·ÁÀÇ´ë), Á¤´ë¿µ (°¡Å縯ÀÇ´ë) |
09:10-09:35 | Machine learning application in GI cancer research from integrated omics data and discovery of clinical insights | ±èÁ¤¾È (°í´ë±¸·Îº´¿ø ¾Ï¿¬±¸¼Ò) |
09:35-10:00 | Understanding microRNA as biomarkers and potential therapeutic targets in pancreatobiliary cancer | ¹ÚÁø¼® (ÀÎÇÏÀÇ´ë) |
10:00-10:25 | Introduction to theranosis: an overview of current approaches and potential applicability to GI cancer | ÀÓÀÏÇÑ (¿øÀڷº´¿ø ÇÙÀÇÇаú) |
10:25-10:45 | Coffee break | |
Session II | Plenary Free Paper Presentation | ÁÂÀå: ÁøÀ±Å (°í·ÁÀÇ´ë), ¹æ½Â¹Î (¿¬¼¼ÀÇ´ë) |
10:45-11:00 | ÃéÀå¾Ï¿¡¼ ATR ¾ïÁ¦¸¦ ÅëÇÑ oxaliplatin ÀúÇ×¼º ±Øº¹¿¡ °üÇÑ ¿¬±¸ | ÀüÁß¿ø (±¹¸³¾Ï¼¾ÅÍ) |
11:00-11:15 | Usefullness of endoscopic removal of occluded fully covered self-metallic stent in patients with malignant distal biliary obstruction | À̽ÿµ (¿¬¼¼ÀÇ´ë) |
11:15-11:30 | Factors associated with gastric and duodenal neuroendocrine tumors: a multicenter case-control study in South Korea | ³²±¤¿ì (´Ü±¹ÀÇ´ë) |
11:30-11:45 | Robot assisted gastric ESD significantly improves dissection speed in difficult ESD locations | ±è»óÇö (°í·ÁÀÇ´ë) |
11:45-12:00 | A scoring model to predict the clinical outcome of self-expandable metal stents in patients with colorectal obstruction due to extracolonic malignancy | ±èÀ±¾Æ (¿¬¼¼ÀÇ´ë) |
12:25-12:50 | (»ç) °Ç°»çȸ¸¦ À§ÇÑ ¼Òȱâ¾Ï ¿¬±¸È¸ Á¤±âÃÑȸ | |
12:50-13:20 | Lunch | |
Session III | Updates On the Treatment of Metastatic Gastrointestinal Tract Cancer | ÁÂÀå: ±è¼º¼ö (°¡Å縯ÀÇ´ë), ¹Ú¼±ÀÚ(°í½ÅÀÇ´ë) |
13:20-13:45 | Treatment of colorectal cancer hepatic metastasis | ÃÖ±âÈ« (¿¬¼¼ÀÇ´ë ¿Ü°ú) |
13:45-14:10 | Treatment of colorectal cancer lung metastasis | °¹Î¿õ (Ãæ³²ÀÇ´ë ÈäºÎ¿Ü°ú) |
14:10-14:35 | Conversion surgery after chemotherapy for inoperable gastric cancer | ÀüÇÑÁ¶ (°í·ÁÀÇ´ë) |
14:35-15:00 | New targets and agents in upper GI cancer (other than HER2) | ½É¼±Áø (°¡ÃµÀÇ´ë Á¾¾ç³»°ú) |
15:00-15:20 | Coffee break | |
Session IV | Free Paper Presentation (1) | ÁÂÀå: ÀÌÇ׶ô (ÇѾçÀÇ´ë), ÁÖ±¤·Î (°æÈñÀÇ´ë) |
15:20-15:35 | Prognosis prediction according to the expression level of immunochemistry staining using methionyl-tRNA synthetase 1 antibody in pancreatic cancer | À强ÀÏ (¿¬¼¼ÀÇ´ë) |
15:35-15:50 | Augmented effect of irreversible electroporation following near-infrared irradiation on gastric neoplasm: an experimental study | ±èµ¿È¯ (°í·ÁÀÇ´ë) |
15:50-16:05 | Prediction of LN metastasis from whole slide pathology images of early gastric cancer using a two step machine learning approach | À̺¸¹Ì (°í·ÁÀÇ´ë) |
Session IV | Free Paper Presentation (2) | ÁÂÀå: ¹®Á¤¼· (ÀÎÁ¦ÀÇ´ë), ¿ì»ó¸í (±¹¸³¾Ï¼¾ÅÍ) |
16:00-16:20 | Novel liquid biopsy strategy for cholangiocarcinoma diagnosis based on plasmon-enhanced single extracellular vesicle analysis | Á¶ÁßÇö (¿¬¼¼ÀÇ´ë) |
16:20-16:35 | Risk factors for early and late-onset cholecystitis after y-configured metal stent placement in patients with malignant hilar obstruction: a single-center experience | ÀÌÁ¾Çö (ºÎ»êÀÇ´ë) |
16:35-16:50 | Effect of ultra-processed food intake on the risk of colorectal cancer: results from two nationwide long-term follow-up studies in Korea | ÃÖÀ±ÀÌ (±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø) |
16:50-17:00 | Best Presentation Award | |
17:00 ~ | Adjourn |